Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

Press releases published on March 3, 2026

Mar. 3, 2026

Inteleos 2026 Leadership Elections Accelerate Vision for Global Healthcare

Indeterminate GlobeNewswire

Mar. 3, 2026

Mount Sinai and King Saud University Medical City Forge a Three-Year Collaboration to Advance Precision Medicine in Familial Inflammatory Bowel Disease

Indeterminate GlobeNewswire

Mar. 3, 2026

Psyence BioMed Announces Export of GMP-Manufactured Natural Psilocybin (NPX-5) to Australia for Ongoing Phase IIb Clinical Trial

Indeterminate GlobeNewswire

Mar. 3, 2026

Tekton Research Appoints Dr. Jara McDonald as Executive Medical Director to Support Continued Growth in Cardiometabolic Research

Indeterminate GlobeNewswire

Mar. 3, 2026

NovaBridge to Host Business Update Call to Review Phase 2a Data for VIS-101 in Wet AMD on Monday, March 9, 2026

Indeterminate GlobeNewswire

Mar. 3, 2026

Senti Biosciences to Present at Leerink Partners 2026 Global Healthcare Conference

Indeterminate GlobeNewswire

Mar. 3, 2026

Connect Biopharma to Present at the Leerink Partners Global Healthcare Conference

Indeterminate GlobeNewswire

Mar. 3, 2026

LivTech Announces Strategic Executive Appointments of Ron Kozlin, CFO and Andrew Goode, VP of Development

Indeterminate GlobeNewswire

Mar. 3, 2026

PathAI Receives U.S. FDA Breakthrough Device Designation for PathAssist Derm, an AI-Powered Pathology Solution to Transform Dermatopathology Workflow

Indeterminate GlobeNewswire

Mar. 3, 2026

Exagen Inc. to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Mar. 3, 2026

LiveWorld Launches Integrated GEO, AIO and SEO Search Optimization for Healthcare and Pharma Brands

Indeterminate GlobeNewswire

Mar. 3, 2026

Hot Springs Arkansas Neurologist Kara Way Opens New Way Neurology

Indeterminate GlobeNewswire

Mar. 3, 2026

PharmAla Signs Supply & Data Agreement with Nautilus Sanctuary for Phase 2 MDMA Clinical Trial Treating Post-Traumatic Stress and Adjustment Disorder in Frontline Healthcare Workers and First Responders

Indeterminate GlobeNewswire

Mar. 3, 2026

Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event

Indeterminate GlobeNewswire

Mar. 3, 2026

Just Salad and God’s Love We Deliver Introduce the Miso Mission Salad for National Nutrition Month

Indeterminate GlobeNewswire

Mar. 3, 2026

Immix Biopharma to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Mar. 3, 2026

INVO Fertility’s Wisconsin Clinic Joins Progyny Network

Indeterminate GlobeNewswire

Mar. 3, 2026

Propanc Biopharma’s Lead Asset PRP Shows >85% Tumor Growth Inhibition in Preclinical Pancreatic Models

Indeterminate GlobeNewswire

Mar. 3, 2026

Neuronetics to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call

Indeterminate GlobeNewswire

Mar. 3, 2026

Fulcrum Therapeutics to Participate in the Leerink Partners Global Healthcare Conference

Indeterminate GlobeNewswire